Literature DB >> 24001699

Point-of-care tests in suspected acute myocardial infarction: a systematic review.

Madeleine H E Bruins Slot1, Geert J M G van der Heijden, Saskia D Stelpstra, Arno W Hoes, Frans H Rutten.   

Abstract

BACKGROUND: A review of cardiac point-of-care (POC) tests used to detect or exclude acute myocardial infarction (AMI) with a focus on test performance within 6 hours after the start of symptoms.
METHODS: A systematic review of articles on the diagnostic accuracy of point of care (POC) tests in patients suspected of AMI from the PubMed database from January 1st 1990 to December 1st 2012.
RESULTS: Our search yielded 42 studies evaluating POC tests. Troponin (Tn) was investigated in 29 studies, and creatine kinase-myocardial band isoenzyme (CK-MB), myoglobin, and heart-type fatty acid-binding protein (H-FABP) each in 13 studies. Eight studies used a multimarker approach. In 14 studies results were presented or could be recalculated for test results within 6 hours of symptom onset or with a median time from symptoms onset to testing of 3 hours. In this time frame the negative predictive value (NPV) ranged from 31 to 97% with single testing, and from 59 to 100% with a multi-marker approach. Just one study satisfied to all items used for methods appraisal.
CONCLUSIONS: The ideal POC test for the diagnosis of AMI within 6 hours after the onset of symptoms does not yet exist. Evaluated POC tests were in general of poor methodological quality and reported too many false negatives to be considered as save for the assessment of patients suspected of AMI. A POC test of high-sensitive troponin could possibly fill the gap in the early hours after symptom onset, especially in those with non-definitive electrocardiography.
© 2013.

Entities:  

Keywords:  Acute myocardial infarction; Biomarkers; Diagnosis; Point of care test; Systematic review

Mesh:

Substances:

Year:  2013        PMID: 24001699     DOI: 10.1016/j.ijcard.2013.08.002

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Development and preliminary validation of infrared spectroscopic device for transdermal assessment of elevated cardiac troponin.

Authors:  Jitto Titus; Alan H B Wu; Siddharth Biswal; Atandra Burman; Shantanu P Sengupta; Partho P Sengupta
Journal:  Commun Med (Lond)       Date:  2022-04-13

2.  Consequences of high-sensitivity troponin T testing applied in a primary care population with chest pain compared with a commercially available point-of-care troponin T analysis: an observational prospective study.

Authors:  Per O Andersson; Jan-Erik Karlsson; Eva Landberg; Karin Festin; Staffan Nilsson
Journal:  BMC Res Notes       Date:  2015-06-03

3.  The value of signs, symptoms and plasma heart-type fatty acid-binding protein (H-FABP) in evaluating patients presenting with symptoms possibly matching acute coronary syndrome: background and methods of a diagnostic study in primary care.

Authors:  Robert T A Willemsen; Frank Buntinx; Bjorn Winkens; Jan F Glatz; Geert Jan Dinant
Journal:  BMC Fam Pract       Date:  2014-12-12       Impact factor: 2.497

4.  Chest pain in general practice: a systematic review of prediction rules.

Authors:  Ralf E Harskamp; Simone C Laeven; Jelle Cl Himmelreich; Wim A M Lucassen; Henk C P M van Weert
Journal:  BMJ Open       Date:  2019-02-27       Impact factor: 2.692

5.  Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis.

Authors:  Jesse P A Demandt; Jo M Zelis; Arjan Koks; Geert H J M Smits; Pim van der Harst; Pim A L Tonino; Lukas R C Dekker; Marcel van Het Veer; Pieter-Jan Vlaar
Journal:  BMJ Open       Date:  2022-04-05       Impact factor: 2.692

Review 6.  Detection of COVID-19-related biomarkers by electrochemical biosensors and potential for diagnosis, prognosis, and prediction of the course of the disease in the context of personalized medicine.

Authors:  Viviana Vásquez; Jahir Orozco
Journal:  Anal Bioanal Chem       Date:  2022-08-16       Impact factor: 4.478

7.  The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care.

Authors:  Michelle M A Kip; Hendrik Koffijberg; Marco J Moesker; Maarten J IJzerman; Ron Kusters
Journal:  BMC Cardiovasc Disord       Date:  2017-08-02       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.